Podcasts about early detection

What does it look like to take a neuroscience degree far beyond the lab? In this episode, we explore a career path that crosses scientific research, government regulation, and biotech entrepreneurship with Dr. Amanda Wiggins, CEO of The cGP Lab. Amanda began her career investigating neurodegeneration and cortical spreading depression. Over time, her passion for real-world impact led her into public policy—where she helped shape New Zealand's Human Tissue Act and advised on regulations for stem cell research and genetic technologies. Today, she leads a company advancing neuroprotective health supplements based on cyclic Glycine-Proline (cGP), a molecule with growing potential in aging and cognitive health. We talk about: How to navigate transitions between academia, government, and business The challenges of working across disciplines—and how to build confidence in new spaces Lessons learned from leading regulatory change and scaling innovation Amanda's work at The cGP Lab and the science behind cGP's potential in brain health Advice for scientists who want to move into leadership, entrepreneurship, or public engagement This conversation is for anyone considering a non-linear career in neuroscience or wondering how to apply scientific training in new and meaningful ways. Chapters: 00:00:02 - Bridging Neuroscience and Biotech Innovation 00:04:06 - FDA Approval of Trofinetide for Rett Syndrome 00:07:27 - My Journey in Science and Identity 00:09:22 - Pursuing a PhD in Melbourne 00:11:55 - Choosing a PhD Topic 00:17:26 - Challenges and Motivation in PhD Journey 00:20:54 - Transition from Academia to Regulatory Work 00:22:52 - Transitioning from Academia to Policy 00:25:51 - Advising on the Human Tissue Act 00:29:18 - Advocating Biotechnology in New Zealand 00:33:51 - Regulations and Challenges in Biotechnology 00:37:49 - Newborn Blood Screening and Research Ethics 00:41:22 - Transitioning from Science to Biotech 00:46:04 - Challenges of Startup Success 00:48:34 - Journey to Neuroactive Innovation 00:55:23 - Mentorship and Startup Advice 00:58:49 - Dementia Prevention and Early Detection 01:02:03 - Exploring Alzheimer's Research Frontiers 01:06:45 - Advancing Your Neurocareer About the Podcast Guest:

Early detection of lung cancer can save lives. In this essential episode, two-time survivor and LCFA co-founder David Sturges shares how screening helped him beat lung cancer—twice. Joined by Dr. Denise Aberle and LCFA-funded researcher Dr. Kellie Smith, this episode dives into why lung cancer is often diagnosed late, what new screening methods can do to change that, and what the future of early treatment might look like. Guests David Sturges, Lung Cancer Survivor & LCFA Co-founder  Dr. Denise Aberle, Thoracic Radiologist, UCLA Medical Center Kellie Smith, Ph.D., Assistant Professor of Oncology, Johns Hopkins University & LCFA Early Career Researcher Show Notes | Transcript  

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, I had the privilege of speaking with Bob Furniss, a father, husband, and author who has turned his family's heartbreaking experience with breast cancer into a mission to educate and advocate for early detection. Bob and his wife Susan founded the nonprofit WarriorPrincess.org in honor of their late daughter, Keisha Furniss, who was diagnosed with metastatic breast cancer at the age of 30.Bob shared the emotional journey of Keisha's diagnosis, treatment, and the impact it had on their family. He recounted how Keisha's initial symptoms were misdiagnosed and how the eventual discovery of her cancer came as a shock. Despite the devastating news, Keisha faced her illness with incredible strength and resilience, earning the nickname "Warrior Princess."This episode is a poignant reminder of the impact of breast cancer on families and the power of turning grief into purposeful action. I hope you find inspiration in Bob's story and are encouraged to have those crucial conversations about breast health with their loved ones.SURVIVINGBREASTCANCER.ORGAttend a free virtual SurvivingBreastCancer.org program (support groups, yoga, medication, expressive writing, art expression, and more!):https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.Resources discussed on this episode:Warrior Princess: https://warriorprincess.org/:On to Blue: https://www.amazon.com/Blue-Breast-Cancer-Warrior-Through/dp/B0DYQDWXVZFit, Healthy & Happy Podcast Welcome to the Fit, Healthy and Happy Podcast hosted by Josh and Kyle from Colossus...Listen on: Apple Podcasts SpotifySupport the show

AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm CME Available: https://auau.auanet.org/node/43021 At the conclusion of this activity, participants will be able to: 1. Apply the Early Detection of Prostate Cancer: AUA/SUO Guideline (2023), and understand the rationale, evidence, level of evidence, strength of recommendation and applications associated with each statement. 2. Maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically significant prostate cancer, while avoiding unnecessary biopsies and detection of clinically insignificant prostate cancers. 3. Describe the evidence supporting the use of PSA for early detection of prostate cancer, and apply that evidence to different clinical scenarios, incorporating patient characteristics and preferences. 4. Identify available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use, and the clinical scenarios in which they are most valuable to be used. 5. Use MRI and fusion biopsy to enhance the detection of clinically significant prostate cancer and implement safe biopsy practices with respect to approach, avoidance of infection, and attention to patient comfort; understand the rationale for transperineal prostate biopsy and its technique; be able to establish a transperineal biopsy practice. ACKNOWLEDGEMENTS: This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Erica Campbell walked away from corporate life, took a hard left from the British Embassy, and found her calling writing checks for families nobody else sees. As Executive Director of Pinky Swear Foundation, she doesn't waste time on fluff. Her team pays rent, fills gas tanks, and gives sick kids' parents the one thing they don't have—time. Then, breast cancer hit her. She became the patient. Wrote a book about it. Didn't sugarcoat a damn thing. We talk about parking fees, grief, nonprofit burnout, and how the hell you decide which families get help and which don't. Also: AOL handles, John Hughes, and letters from strangers that make you cry. Erica is part Punky Brewster, part Rosie the Robot, and part Lisa Simpson—with just enough GenX Long Island sarcasm to make it all land. This one sticks.RELATED LINKSPinky Swear FoundationThe Mastectomy I Always Wanted (Book)Erica on LinkedInThink & Link: Erica Campbell“Like the Tale of a Starfish” - Blog Post“Cancer Diagnosis, Messy Life, Financial Support” - Blog PostFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What do you do when cancer is always present in your family? David Mauk lost his mother, his sister, and other loved ones to breast cancer. He knows what it's like to grow up surrounded by the reality of cancer and to carry the BRCA gene. In today’s episode, you’ll hear: How genetic testing changed the choices his family made What it feels like to be a cancer advocate in Washington, D.C. Why sharing your family history can help save lives Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered What impact did breast cancer have on David Mauk's family? What is the significance of the BRCA gene in David’s family? How did David’s family talk about breast cancer while he was growing up? How did David cope with losing his mother at such a young age? Did David himself undergo genetic testing and what were the results? How does David’s family approach genetic testing and health surveillance today? What has David done as an advocate for cancer research and awareness? Why does David believe early detection and knowing your family history is so crucial? What advice does David have for those with a family history of cancer? How has cancer research and treatment changed since previous generations? Timestamped Overview 00:00 Family, Cancer, Advocacy, Gene Awareness 04:31 Air Force Headsets Linked to Tumors 07:36 "Air Force Brat’s Journey" 11:07 Cancer Society Fundraising Champions 14:11 "Make Cancer Conversations Personal" 15:41 "Missing Maternal Memories" 22:00 Family Migration Journey 22:57 Living Positively Amidst Fear 25:57 Discovering Family Through DNA Insights 29:37 Empowering Young Women Against Breast CancerSee omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Allyson with a Y. Ocean with two Ls. And zero chill when it comes to changing the face of cancer care. Dr. Allyson Ocean has been quietly—loudly—at the center of every major cancer breakthrough, nonprofit board, and science-backed gut punch you didn't know you needed to hear. In this episode, she joins me in-studio for a conversation two decades in the making. We talk twin life, genetics, mitochondrial disease, and why she skipped the Doublemint Twins commercial but still ended up as one of the most recognizable forces in oncology. We cover her nonprofit hits, from Michael's Mission to Let's Win Pancreatic Cancer to launching the American Jewish Medical Association—yes, that's a thing now. We get personal about compassion in medicine, burnout, bad food science, and microplastics in your blood. She also drops the kind of wisdom only someone with her résumé and sarcasm can. It's raw. It's real. It's the kind of conversation we should've had 20 years ago—but better late than never.RELATED LINKS:– Dr. Allyson Ocean on LinkedIn– Let's Win Pancreatic Cancer– NovoCure Leadership Page– Michael's Mission– American Jewish Medical Association– The POLG Foundation– Cancer Buddy App (Bone Marrow and Cancer Foundation)– Dr. Ocean at OncLiveFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today, I am excited to welcome Andrea Tolle as my guest. Andrea is a clinical thermographer who does thermographic scans at our clinic each month. In this episode, she explains what thermography does, how it works, and how it differs from other routine scans. Andrea's Tips for Improving Lymphatic Flow:  Do a self-lymphatic massage Do skin-brushing Eat cleanly  Drink clean water  Wear looser clothing Reduce your stress  Care for yourself well Andrea Tolle's Bio: Andrea Tolle is a Clinical Thermographer.  She became certified through the American College of Clinical Thermography in 2020. She values offering clients a proactive screening tool for breast health that gives them physiological information and can show stability or changes over time.  Since needing to eat gluten-free in 1995, she's been interested in health and holistic lifestyles & modalities. She was an organic produce vendor for over 20 years and knows about food quality and toxicities in the environment. Andrea has also been practicing homeopathy since 2015 and is nationally certified through the Council of Homeopathic Certification (CHC).  She encourages the awareness of using discernment and wisdom to embody self-empowerment vs making fear-based health decisions.  Ultimately your body belongs to you. You can choose to be in charge of YOU, and you can be mindful of what is influencing your health decisions. She envisions the end of “sick care” and the prospering of true “health care” as: Working with providers that value cooperation, trust, and respect while honoring the intelligence of the human body. She offers thermography scans in the Cedar Rapids & Clear Lake Iowa areas, and in SE MN. In this episode: How her initial experience with gluten sensitivity in 1995 led Andrea to a healthier lifestyle What is thermography? Andrea describes the process of getting a thermography scan done How thermography can help with the early detection and monitoring of physical abnormalities How thermologists interpret thermography reports Why you need to ensure that your lymphatic flow is functioning well How thermography differs from ultrasound and mammograms Links and Resources: Use Code DIM to get 10% off DIM⁠ Use code Bvitamins to get 10% off ⁠METHYL B COMPLEX Relative Links for This Show: Thermography – Green Compass Homeopathy Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

Noxious weeds are one of the most costly and challenging threats to Montana's agricultural economy and natural ecosystems. With 36 officially designated noxious weed species, the state is losing millions of dollars annually due to reduced livestock forage, increased land […] The post Early Detection, Rapid Response – Montana Noxious Weed Awareness Week first appeared on Voices of Montana.

What if the key to better health isn't treatment—it's prevention?In this episode of The Healthy Project Podcast, Corey Dion Lewis breaks down the true meaning of preventative health and why it matters. From early screenings to lifestyle changes, Corey explains how staying ahead of illness can save money, boost energy, and extend your life.We cover:What counts as preventative careHow early detection worksWhy prevention puts you in control of your healthSimple steps you can take todayThis isn't about reacting. It's about being ready.Subscribe, rate, and share with someone who needs a reminder to book that checkup. ★ Support this podcast ★

Sponsored by Invivyd, Inc.Nobody wants to hear about COVID-19 anymore. Especially not cancer patients. But if you've got a suppressed immune system thanks to chemo, radiation, stem cell transplants—or any of the other alphabet soup in your chart—then no, it's not over. It never was. While everyone else is getting sweaty at music festivals, you're still dodging a virus that could knock you flat.In this episode, Matthew Zachary and Matt Toresco say the quiet part out loud: many immunocompromised people may not even know they have options beyond vaccines. Why? Because the system doesn't bother to tell them. So we're doing it instead. We teamed up with Invivyd to help get the word out about tools other than vaccines that can help prevent COVID-19. We break down the why, the what, and the WTF of COVID-19 risk for cancer patients and why every oncologist should be talking about this.No fear-mongering. No sugarcoating. Just two guys with mics who've been through it and want to make sure you don't get blindsided. It's fast, funny, and furious—with actual facts. You've got more power than you think. Time to use it.RELATED LINKSExpand Their OptionsInvivydMatt Toresco on LinkedInOut of Patients podcastFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Andrea Donsky, nutritionist, published menopause researcher, menopause Educator, and co-founder of WeAreMorphus.com interviews Dr. Erin Glynn, PhD, an expert in metabolism and exercise physiology, who shares her personal journey with breast cancer at age 42. From her unexpected diagnosis to treatment decisions, Erin offers valuable insights both as a researcher and patient.Our podcast has been recognized as the top-ranked menopause podcast worldwide on Feedspot's 2025 list of best Menopause Podcasts and Perimenopause Podcasts.Key Topics:Early detection and the importance of regular screeningsUnderstanding treatment options including surgery, radiation, and endocrine therapyHow to advocate for yourself in the healthcare systemThe role of mindset in cancer treatment and recoveryFeatured Resources:Dr. Glynn's website: nuchihealth.comEstrogen Matters: Why Taking Hormones in Menopause Can Improve and Lengthen Women's Lives -- Without Raising the Risk of Breast Cancer https://amzn.to/4dGZ66b The Power of Aggressive Positivity: A Conversation with Limore Zisckind https://youtu.be/GMHvqRrZKjcAggressive Positivity https://amzn.to/43if2InSend us a text ✅ Fill out our surveys

In this episode, Dr. Torin Cunningham, medical director of the Orthopedic Center at Miller Children's & Women's Hospital, will discuss scoliosis in children – a condition that, when detected early, can lead to better long-term outcomes. Dr. Cunningham will explain what scoliosis is, how to recognize early signs, and why timely screening is important. Listeners will learn about the latest technology, when to screen their children, and how families can play a key role in early intervention.

In this episode, Jonathan Sackier kicks off a special miniseries on lung cancer with Haval Balata, Consultant Respiratory Physician at Manchester University NHS Foundation Trust. From the Manchester Lung Health Check to robotic bronchoscopy, Balata shares insights into pioneering early detection efforts, the challenge of public misconceptions, and innovations reshaping lung cancer screening and diagnosis. Timestamps: 03:12 – Inspiration to specialise 04:09 – Early diagnosis barriers 08:02 – Manchester Lung Health Check 14:10 – Robot-assisted bronchoscopy 19:24 – Public misconceptions 28:57 – Risk stratification & follow-up 34:24 – Innovations in early detection 37:10 – Hopes for the future 41:22 – Three healthcare wishes

EPISODE DESCRIPTIONLisa Shufro is the storyteller's storyteller. A musician turned innovation strategist, TEDMed curator, and unapologetic truth-teller, Lisa doesn't just craft narratives—she engineers constellations out of chaos. We go way back to the early TEDMed days, where she taught doctors, scientists, and technocrats how not to bore an audience to death. In this episode, we talk about how storytelling in healthcare has been weaponized, misunderstood, misused, and still holds the power to change lives—if done right. Lisa challenges the idea that storytelling should be persuasive and instead argues it should be connective. We get into AI, the myth of objectivity, musical scars, Richard Simmons, the Vegas healthcare experiment, and the real reason your startup pitch is still trash. If you've ever been told to “just tell your story,” this episode is the permission slip to do it your way. With a bow, not a violin.RELATED LINKSLisa Shufro's WebsiteLinkedInSuper Curious ArchiveEight Principles for Storytelling in InnovationStoryCorps InterviewCoursera Instructor ProfileWhatMatters ProjectFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join host Jennifer Semenza as she speaks with Dr. Kelly Perlewitz, Acting Director of Hematology and Oncology at Providence Cancer Institute. Dr. Perlewitz discusses the importance of early cancer detection and shares practical tips for prevention. Learn about various cancer screenings, lifestyle changes, and the role of genetics in cancer development. Dr. Perlewitz also highlights the significance of mental health in treatment and offers advice on supporting loved ones through a cancer diagnosis. Do you want to know more?Check out the Providence blog for more information on this and other health related topics. How to help protect yourself against cancer | ProvidenceEarly awareness is key to combating head and neck cancerLung Cancer Screening Saves LivesMapping your health journey with genetics testingTo learn more about our mission programs and services, go to Providence.org.Follow us on social media to get continued information on other important health care topics. You can  connect with us on LinkedIn, Facebook, TikTok, Instagram and X.For all your healthcare information on the go, download the Providence app. Whether you're tracking symptoms, scheduling appointments, or connecting with your healthcare providers, the Providence app has your back.To learn more about the app, check out the Wellness Brief podcast episode. Wellness Brief: Simplifying Care-There's an App for That. We'd love to hear from you. You can contact us at FutureOfHealthPodcasts@providence.org

Tuesday, May 27-  Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with President Biden's metastatic prostate cancer, why people are questioning when he was actually diagnosed and if there was dishonesty when many were questioning his health while he was still in office. Then, news of the first-ever human bladder transplant takes place in Southern California, good news for migraine sufferers as an already approved migraine medication can stop early-migraine symptoms hours before the headache itself even begins. Next, Dr. Ken sheds light on the dos and don'ts of recovering after a heart attack, and how loneliness affects your mental and physical health. Listener questions close up the conversation with “when is the best time of day to weigh yourself,” and the fact that your weight can vary up to 8 pounds during the day, which is why first thing in the morning, post morning bathroom break but before you've eaten or drank anything, is the best time of day. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

At 57, Ronnie was living a healthy, active life as a health coach, marathon runner, and triathlete. She had always taken great care of her health and never imagined that cancer would be part of her story—until June of 2018 after a routine colonoscopy, Ronnie was diagnosed with stage 4 colon cancer that had spread to liver, lungs, peritoneum and lymph nodes.   Faced with this grim prognosis, she chose to take an active role in her treatment. Ronnie opted for traditional chemotherapy but also incorporated naturopathic treatments into her regimen. Ronnie believed this combination would help support her body during the chemotherapy and aid in her healing. The journey wasn't easy, but the balance of conventional medicine and natural therapies helped her to stay strong and cope with the challenges she faced. Looking back, Ronnie realizes that her success wasn't just the result of traditional treatments or naturopathic therapies—it was her mindset, resilience, and refusal to give up. Cancer tried to take her life, but instead, it gave her a new one, one filled with gratitude, strength, and a deeper understanding of what truly matters. To learn more about Ronnie and her work visit, https://ronniecampbellauthor.com/ To purchase her book, Racing for a Miracle: A Stage 4 Survivor's Journey of Hope. Celebrating 5 Years Cancer-Free—A Story of Strength, Early Detection, and Miracles, visit https://ronniecampbellauthor.com/about-the-book/ Instagram @ronniecampbellauthor.com (https://www.instagram.com/ronniecampbell.author/) Facebook @ronnieswellness4life.com ( https://www.facebook.com/profile.php?id=100083650758740  )  Learn more about Colorectal Cancer Canada at https://www.colorectalcancercanada.com/ _________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _____ Thank you to our friends from The Healing Oasis for sponsoring this episode of the podcast.  The Healing Oasis is a first of its kind in beautiful British Columbia, Canada where we encourage the body to heal from cancer using alternative therapies & cancer fighting meals at a wellness retreat center in nature. Our top naturopathic cancer doctor will prescribe a protocol tailored specifically for you. There's no place quite like it. Start your healing journey today! Learn More about The Healing Oasis by visiting these links: Website   Testimonials Video Overview

What happens when you blend the soul of Mr. Rogers, the boldness of RuPaul, and just a pinch of Carrie Bradshaw? You get Sally Wolf.She's a Harvard and Stanford powerhouse who ditched corporate media to help people actually flourish at work and in life—because cancer kicked her ass and she kicked it back, with a pole dance routine on Netflix for good measure.In this episode, we unpack what it means to live (really live) with metastatic breast cancer. We talk about the toxic PR machine behind "pink ribbon" cancer, how the healthcare system gaslights survivors when treatment ends, and why spreadsheets and dance classes saved her sanity. Sally doesn't just survive. She rewrites the script, calls out the BS, and shows up in full color.If you've ever asked “Why me?”—or refused to—this one's for you.RELATED LINKS:Sally Wolf's WebsiteLinkedInInstagramCosmopolitan Essay: "What It's Like to Have the 'Good' Cancer"Oprah Daily Article: "Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis"Allure Photo ShootThe Story of Our Trauma PodcastFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This podcast was created using Notebook LM.This podcast focuses on the critical importance of early detection of oral pre-cancer, emphasizing that these potentially malignant lesions often begin subtly and without pain. It explains that pre-cancerous conditions are abnormal cell changes in the mouth that can develop into cancer if not treated.

“A lot of other disease sites, they have some targeted therapies, they have some immunotherapies [IO]. In lung cancer, we have it all. We have chemo. We have IO. We have targeted therapies. We have bispecific T-cell engagers. We have orals, IVs. I think it's just so important now that, particularly for lung cancer, you have to be well versed on all of these,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer treatment. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 16, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer treatments. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episode: Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Lazertinib Oncology Drug Reference Sheet: Nivolumab and Hyaluronidase-Nvhy Oncology Drug Reference Sheet: Fam-Trastuzumab Deruxtecan-Nxki Optimize Your Testing Strategy and Improve Patient Outcomes With NeoGenomics' Neo Comprehensive™–Solid Tumor Assay Clinical Journal of Oncology Nursing article: Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse ONS Biomarker Database ONS video: What is the role of the KRAS biomarker in NSCLC? Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool ONS Huddle Cards: Checkpoint inhibitors External beam radiation Monoclonal antibodies Proton therapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, because lung cancer is pretty aggressive, we'll see lung cancer mostly in stage IV. So about 50%–55% of all cases are not caught until they are already metastatic, or stage IV. And then about another 25%–30% of cases are caught in stage III, which means they're locally advanced and often not resectable, but we do still treat that with curative intent with concurrent chemoradiation. And then 10%–20% of cases are found in the early stage, and that's stage I and II, where we can do surgical approaches.” TS 2:53 “The majority of radiation that you're going to see is for patients with stage III disease that's inoperable. At my institution, a lot of stage III is inoperable. Now, neoadjuvant immunotherapy has changed that a little bit. But if you have several big, bulky, mediastinal lymph nodes that makes you stage III, surgery is probably not going to be a great option. So we give curative-intent chemoradiation to these patients.” TS 10:51 “Oligoprogression would mean they have metastases but only to one site. And sometimes we will be aggressive with that. Particularly, there's good data, if the only site of progression is in the brain, we can do stereotactic radiation to the brain and then treat the chest with concurrent chemoradiation as a more definitive approach. But outside of that, the majority of stage IV lung cancer is going to be treated with systemic therapy.” TS 15:00 “It's important for nurses to know that there's a lot of different options now for treatment. Probably one of the most important things is making sure patients are aware of what their biomarker status is, what their PD-L1 expression level is, and make sure those tests have been done. … It's good that the patients understand that there's a myriad of options. And a lot of that depends on what we know about their cancer, and then that guides our treatment.” TS 31:05

In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia's future goals, including expanding their AI applications to detect other health conditions.   If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.   Founder Bio:   Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.      Time Stamps:   00:36 Christina's Professional Journey 04:00 Founding Prosperia and Developing Retinia 05:43 Addressing Diabetic Retinopathy with AI 07:10 Challenges in Diabetic Retinopathy Detection 09:32 AI's Role in Early Detection and Screening 13:33 How does the Retinia software diagnosis work 15:20 The role of AI versus human doctors 20:43 Building and Training AI Models 24:31 Balance between engineers and health care professionals 26:14 Creating a customer base that trusts AI diagnosis 32:53 Fundraising and Growth Strategies 40:45 Advantages of Fundraising in Latin America Compared to the U.S. 44:01 Future Plans and Innovations   Resources   Follow Darius Gant LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/ Company Website - www.tesoroai.com     Subscribe on Spotify: https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n   Subscribe on Apple Podcast: https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104   Company website: https://www.prosperia.health/es LinkedIn: https://www.linkedin.com/company/prosperia/ https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/  

Dr. Dale Bredesen, a renowned expert in the field of neurodegenerative diseases, is on a mission to reshape the way we think about aging and brain health. He challenges conventional perceptions about aging, emphasizing the importance of maintaining a "brain span" that matches one's lifespan. Often posing thought-provoking questions about longevity, Dr. Bredesen highlights the undesirability of living to an advanced age if it means suffering from dementia. His work, driven by ongoing research and encapsulated in his latest book, aims to shift the narrative from expecting cognitive decline with age to implementing proactive strategies for preserving brain function. Timestamps: 05:24 Brain Health Over Longevity 07:53 Exercise, Memory, and APOE4 Gene Impact 10:26 Optimizing Cognition: Early Detection's Role 14:56 Herpes and Toxins Linked to Cognitive Decline 17:38 Neurotransmitters, Choline, and Stress Impact 20:43 Tau's Role in Brain Health 24:57 Understanding Cognitive Health Markers 26:43 Misdiagnosed Alzheimer's Story 30:51 Optimal Diet and Fasting Guidelines 33:35 Expanding Exercise Benefits in Neurology 39:11 Early Detection in Alzheimer's Prevention

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:Why early detection is key for improving patient outcomesHow to monitor through use of noninvasive imaging and biopsy per guideline recommendationsHow to coordinate patient care to provide much-needed multidisciplinary careWhat therapies in the pipeline could transform the treatment landscape for this genetic disease PresentersPaula Henao, MDAssistant Professor of MedicineDivision of Pulmonary, Allergy and Critical Care MedicinePenn State Hershey Medical CenterHershey, PennsylvaniaRohit Loomba, MD, MHScProfessor of MedicineChief, Division of Gastroenterology and HepatologyDirector, MASLD Research CenterUniversity of California, San DiegoSan Diego, CaliforniaCheryl Pirozzi, MD, MSAssociate Professor of Internal MedicineDivision of Pulmonary and Critical Care MedicineUniversity of UtahSalt Lake City, UtahCorinne Young, NP, FCCPPresident/FounderAssociation of Pulmonary Advanced Practice ProvidersColorado Springs, ColoradoLink to full program: https://bit.ly/4dgCRnq

Is there a blood test for Alzheimer's? What causes colon cancer? How many measles cases in 2025? Is bird flu still an issue? What outbreaks are happening right now? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the first measles cases of the year in new U.S. cities, and avian flu outbreaks in dairy cattle and poultry. Also discussing a recent survey on Alzheimer's disease and new research suggesting links between gut bacteria and colon cancer in younger adults. American Medical Association CXO Todd Unger hosts.

Could our healthcare system be making us sicker rather than healthier? In the UK, autism diagnoses have increased by a staggering 787% between 1998 and 2018, and one in five people now has some form of mental health disorder. But what if some of our health struggles aren't diseases to be cured, but normal human experiences being medicalised? This week, I'm joined by Dr Suzanne O'Sullivan, a consultant in clinical neurophysiology and neurology at The National Hospital for Neurology and Neurosurgery, who specialises in the investigation of complex epilepsy and also has an active interest in psychogenic disorders.  Her latest book, The Age of Diagnosis: Sickness, Health, and Why Medicine Has Gone Too Far, aims to challenge long-held assumptions about medical progress and change the way we think about our health.  In this thought-provoking conversation, we explore: Why giving someone a diagnosis is never neutral – it can fundamentally change how a person views themselves, their body and their future possibilities How the definition of autism has dramatically expanded over the past few decades from its original concept of "extreme autistic aloneness" to now potentially including 1 in 20 children in Northern Ireland Why screening for diseases like prostate cancer can lead to unnecessary treatment The potential problems of genetic testing - when results are misinterpreted or used without proper context, especially with tests that aren't clinical grade Why early detection and treatment aren't always better, particularly when it turns healthy people into patients decades before they might develop symptoms The profound story of how Suzanne diagnosed a rare genetic condition in a 15-year-old girl, only to question whether she had actually done the right thing by medicalising someone who believed herself to be healthy This is a nuanced, compassionate discussion that challenges many of the widely held assumptions in modern healthcare and I would urge you to listen with an open mind. Throughout our conversation, Suzanne emphasises that she's not arguing against the existence of these conditions or suggesting everyone should refuse diagnosis. Rather, she encourages both patients and doctors to consider whether medicalising our struggles is always the right approach. I hope you enjoy listening.   Support the podcast and enjoy Ad-Free episodes. Try FREE for 7 days on Apple Podcasts https://apple.co/feelbetterlivemore.  For other podcast platforms go to https://fblm.supercast.com.   Thanks to our sponsors: https://thriva.co https://drinkag1.com/livemore https://vivobarefoot.com/livemore https://airbnb.co.uk/host   Show notes https://drchatterjee.com/553   DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening.  This technology can help reduce unnecessary biopsies and additional tests while more accurately identifying cancers that need immediate attention. The concerning trend of rising breast cancer in younger women highlights the importance of early detection and personalized care plans. Dana explains, "Literally, iCAD's first FDA-cleared product in a first-generation AI was around 2002. So it's been well over 20 years. We're now on our fourth generation. So, yes, you're very accurate in describing this as a next-generation approach. So, not only has imaging technology improved over the past 20 years, but artificial intelligence has also improved. We continue to leverage the latest in artificial intelligence technology, how the artificial intelligence can be trained and learn, and a broad base of researchers that help us develop the solution. So you have new minds, new ways to think about solving the problem, and new technology that can be used to solve the problem. Then, there is a new underlying screening technology that gets better and better at clearer imaging." "The American Cancer Society reports that if we can catch a breast cancer very early in stage one, then the likelihood of, I'll say surviving breast cancer is 99%, so very, very high. So the earlier we can catch a breast cancer, the less invasive and costly and length of time the treatments can be. There are more options for those patients as well as the likelihood of a positive outcome, being able to again, have no further evidence of the disease is increased." #iCAD #BreastCancer #BreastCancerScreening #Radiology #CancerDetection #BreastBiopsies #Mammogram #WomensHealth #MedAI icadmed.com Download the transcript here

Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening.  This technology can help reduce unnecessary biopsies and additional tests while more accurately identifying cancers that need immediate attention. The concerning trend of rising breast cancer in younger women highlights the importance of early detection and personalized care plans. Dana explains, "Literally, iCAD's first FDA-cleared product in a first-generation AI was around 2002. So it's been well over 20 years. We're now on our fourth generation. So, yes, you're very accurate in describing this as a next-generation approach. So, not only has imaging technology improved over the past 20 years, but artificial intelligence has also improved. We continue to leverage the latest in artificial intelligence technology, how the artificial intelligence can be trained and learn, and a broad base of researchers that help us develop the solution. So you have new minds, new ways to think about solving the problem, and new technology that can be used to solve the problem. Then, there is a new underlying screening technology that gets better and better at clearer imaging." "The American Cancer Society reports that if we can catch a breast cancer very early in stage one, then the likelihood of, I'll say surviving breast cancer is 99%, so very, very high. So the earlier we can catch a breast cancer, the less invasive and costly and length of time the treatments can be. There are more options for those patients as well as the likelihood of a positive outcome, being able to again, have no further evidence of the disease is increased." #iCAD #BreastCancer #BreastCancerScreening #Radiology #CancerDetection #BreastBiopsies #Mammogram #WomensHealth #MedAI icadmed.com Listen to the podcast here

Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive testing, access to neurologists, and education on lifestyle changes that can support a good quality of life. Their mission is to take a proactive rather than the current reactive approach to diagnosing and slowing the progression of cognitive decline.   Rany explains, "The challenge for us, and this is what I saw from years of clinical practice and hospital management, is that a disease like Alzheimer's operates almost like a green light. Life is okay, you're having minor issues, but for the most part, you're moving along. Then suddenly you notice a sentinel event, which then becomes that red light, and now you have Alzheimer's dementia. And so the issue that is at the core of Alzheimer's is early detection. Is there a way for us to detect things earlier and, in turn, provide patients with an opportunity to take control of their dementia and make the necessary changes in treatments?" "In the current setting, the way that we do it in the United States and around the world is really reactive and it is too late by the time your mother or father is developing cognitive complaints. It's very easy to ignore the early stages of it because you can function for three to five years without really anything dramatic happening. So suddenly, when that dramatic instance occurs, for example, you leave the stove on, or you get lost driving back to your house, something that's very obviously outside of the normal, that might trigger you to say, "Let's get Mom checked." "At launch, our focus is on using the biomarker called p-tau 217. This biomarker can be detected now with more technologies in the blood at microscopic levels, and we couldn't do that effectively 10 or 15 years ago. That science has caught up, and the technology has caught up to a point that now, even 8 to 10 years before any significant clinical symptoms occur, we're able to detect if this protein is elevated. Now, if this protein is elevated, depending on the assay that we use, it's about 93%-97% sensitive for potentially developing Alzheimer's long-term. So it's a good protein to use as a triage protein." #NeurogenBiomarkings #Biomarkers #BloodBiomarkers #Alzheimers #AlzheimersDisease #CognitiveDecline #Dementia #EarlyDetection #Neurologists NeurogenBiomarking.com Download the transcript here 

Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive testing, access to neurologists, and education on lifestyle changes that can support a good quality of life. Their mission is to take a proactive rather than the current reactive approach to diagnosing and slowing the progression of cognitive decline.   Rany explains, "The challenge for us, and this is what I saw from years of clinical practice and hospital management, is that a disease like Alzheimer's operates almost like a green light. Life is okay, you're having minor issues, but for the most part, you're moving along. Then suddenly you notice a sentinel event, which then becomes that red light, and now you have Alzheimer's dementia. And so the issue that is at the core of Alzheimer's is early detection. Is there a way for us to detect things earlier and, in turn, provide patients with an opportunity to take control of their dementia and make the necessary changes in treatments?" "In the current setting, the way that we do it in the United States and around the world is really reactive and it is too late by the time your mother or father is developing cognitive complaints. It's very easy to ignore the early stages of it because you can function for three to five years without really anything dramatic happening. So suddenly, when that dramatic instance occurs, for example, you leave the stove on, or you get lost driving back to your house, something that's very obviously outside of the normal, that might trigger you to say, "Let's get Mom checked." "At launch, our focus is on using the biomarker called p-tau 217. This biomarker can be detected now with more technologies in the blood at microscopic levels, and we couldn't do that effectively 10 or 15 years ago. That science has caught up, and the technology has caught up to a point that now, even 8 to 10 years before any significant clinical symptoms occur, we're able to detect if this protein is elevated. Now, if this protein is elevated, depending on the assay that we use, it's about 93%-97% sensitive for potentially developing Alzheimer's long-term. So it's a good protein to use as a triage protein." #NeurogenBiomarkings #Biomarkers #BloodBiomarkers #Alzheimers #AlzheimersDisease #CognitiveDecline #Dementia #EarlyDetection #Neurologists NeurogenBiomarking.com Listen to the podcast here 

What inspires individuals to turn personal battles into advocacy for others' health? The Hats and Henna High Tea event, born from Ashma Khanani-Moosa's breast cancer journey, has become a beacon of awareness and support through its empowering initiatives. Attendees, including survivors like Mona Ellakany and healthcare professionals, emphasize the significance of early detection and community support in conquering breast cancer. Their shared stories highlight the power of resilience and collective encouragement in overcoming life's toughest challenges. Key Questions Answered 1. What is the purpose of The Rose's Hats and Henna High Tea event? 2. Why is it important to subscribe to the podcast and share it with others? 3. How did Tina Saenz get connected with The Rose, and why is breast cancer prevention important to her? 4. What message does Mona Ellakany have for women battling breast cancer? 5. How did Mazin Ellakany support his mother during her breast cancer journey? 6. What is Yang’s perspective on the importance of convenient access to preventive care? 7. Why does Dr. Abdul Moosa emphasize the importance of early detection and mammography? 8. What contributions has Linlin Yan made to raise awareness of breast cancer in the community? 9. How does Dr. Zainab Alawadi approach the first meeting with a patient diagnosed with breast cancer? 10. How has Kareem Mohammed’s personal experience shaped his view on early cancer detection and support? Timestamped Overview 00:00 Embrace Cancer as a Journey 04:57 Mobile Mammography For Early Detection 09:14 Breast Cancer: Challenges and Support 12:05 Early Detection and Support Crucial Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

In this episode, I'm joined by Dr. Dale Bredesen, a true pioneer in Alzheimer's research and functional medicine. Together, we dive into groundbreaking advancements in the world of neurodegenerative diseases, with a special focus on the exciting breakthroughs in detecting and potentially reversing Alzheimer's and other related conditions. Dr. Bredesen sheds light on the new disease mechanisms and innovative blood tests that are changing the game, showing us that cognitive decline isn't something we simply have to accept. We also explore his integrative approach to combating Alzheimer's, which includes lifestyle modifications, early detection, and a holistic strategy for better brain health. This conversation is packed with hope and real strategies for a future where Alzheimer's doesn't have to be inevitable. Key Takeaways: New Era of Research: Alzheimer's and similar neurodegenerative diseases are not death sentences, thanks to innovative research and new treatment protocols that emphasize early detection and intervention. Significance of Gut Health: Investigations reveal that gut microbiota and inflammation are crucial risk factors in cognitive decline, underscoring the importance of gut health in preventing Alzheimer's. Role of Lifestyle Changes: Diet, exercise, sleep, and stress management are integral to maintaining brain health and can significantly influence the progression of neurodegenerative diseases. Advance in Diagnostics: Cutting-edge blood tests such as P Tau217 and brain scans can detect early signs of Alzheimer's up to 20 years prior to diagnosis, offering opportunities for preemptive action. The Power of Personalized Medicine: Individualized protocols based on genetic testing, like assessing APOE status, are pivotal in developing effective prevention and treatment strategies for cognitive disorders. More About Dr. Dale Bredesen: Dr. Dale Bredesen, M.D., is a globally recognized expert in neurodegenerative diseases, particularly Alzheimer's disease. With a background that includes graduating from Caltech and earning his M.D. from Duke University Medical Center, Dr. Bredesen's career is marked by groundbreaking research and clinical expertise. He completed his residency as chief resident in neurology at UCSF and further honed his skills at Nobel laureate Stanley Prusiner's lab at UCSF as an NIH postdoctoral fellow. Dr. Bredesen's academic career includes faculty positions at prestigious institutions like UCSF, UCLA, and UC San Diego. As the founding president and CEO of the Buck Institute for Research on Aging, he spearheaded pioneering work in the study of aging and neurodegenerative diseases. Currently, he serves as the chief medical officer of MPI Cognition, where he continues his innovative research and efforts to combat Alzheimer's and related conditions. Dr. Bredesen's expertise and leadership have made him a key figure in the field, with a focus on integrative approaches to prevent and reverse cognitive decline. His contributions are reshaping our understanding of neurodegenerative diseases, offering new hope for those affected by them. Website Instagram Take a Cognitive Assessment here: https://www.apollohealthco.com/know-your-cq/ Get a brain scan: https://getabrainscan.com/ KetoFLEX 12/3: https://www.trifectanutrition.com/apollohealthpartner Connect with me! Website Instagram Facebook YouTube   This episode is sponsored by Professional Co-op®, where clinicians gain exceptional access to industry-leading lab services without the hefty price tag—since 2001, they've been redefining what efficient, patient-focused support looks like. Imagine no hidden fees, no minimums, and only paying for completed tests. Experience lab services that not only meet but also exceed your expectations. Join the co-op trusted by countless licensed clinicians nationwide. Visit www.professionalco-op.com to learn more! This episode is also made possible by Functional Medicine University. FMU is a fully online, self-paced training program in functional medicine, founded in 2006 by Dr. Ron Grisanti. With students in all 50 U.S. states and 68 countries globally, FMU has become a cornerstone in advanced clinical education for healthcare practitioners. The curriculum is led by Dr. Grisanti, alongside contributions from over 70 distinguished medical experts on FMU's advisory board. Graduates earn the prestigious Certified Functional Medicine Practitioner (CFMP®) credential upon completion. FMU is also a nationally approved provider of continuing education for a wide range of licensed professionals, including MDs, DCs, DOs, NDs, acupuncturists, PAs, NPs, nurses, dietitians, pharmacists, and dentists. Whether you're looking to expand your clinical knowledge or bring a functional approach to your practice, FMU offers the tools, guidance, and certification to help you thrive. Visit www.functionalmedicineuniversity.com to learn more!

Episode 359: Lung Cancer Screening, Early Detection, and Disparities “I was actually speaking to a primary care audience back a few weeks ago, and we were talking about lung cancer screening. And they said, ‘Our patients, they don't want to do it.' And I said, ‘Do you remind them that lung cancer is curable?' Because everybody thinks it is a death sentence. But when you're talking about screening a patient, I think it's really important to say, ‘Listen, if we find this early, stage I or stage II, our chances of curing this and it never coming back again is upwards of 60% to 70%,'” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer screening. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion Episode 247: Tobacco Treatment for Patients With Cancer ONS Voice articles: Lung Cancer Screening and Early Detection Drastically Improves Survival Rates Pack-Year History Is a Biased and Inadequate Criterion for Lung Cancer Screening Eligibility, Researchers Say CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Clinical Journal of Oncology Nursing articles: Nurse-Led Tobacco Cessation for Veterans Using Motivational Interviewing in a Lung Cancer Screening Program Identifying Primary Care Patients at High Risk for Lung Cancer: A Quality Improvement Study Oncology Nursing Forum article: Patient–Provider Discussion About Lung Cancer Screening Is Related to Smoking Quit Attempts in Smokers ONS Tobacco, E-Cigarettes, and Vaping Learning Library American Cancer Society Lung Cancer Screening Guidelines American Lung Association lung cancer resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, the current state of lung cancer screening is pretty low. Our rate of uptake in eligible patients is somewhere between 6% and 20%. And that falls much further below what we see for screening, such as breast cancer screening, prostate cancer screening, and colorectal cancer screening. So certainly, we can do better.” TS 1:32 “If you quit more than 15 or 20 years, your risk of developing lung cancer at that point is significantly lower. And so that's why once patients have quit more than 15 years, they're actually not eligible for screening anymore—because their risk of developing lung cancer is dramatically reduced. And that takes into account when you are a primary care provider, pulmonary, whatever field you work in, and you are running a screening clinic each year that you screen the patient, you have to remind yourself when they quit smoking, because once they reach that 15 years, then they're no longer eligible for screening.” TS 5:17 “One of the strategies that they've used to get the word out is, I watch a lot of baseball. I love the Philadelphia Phillies, watch Phillies games. And so at least once a year, maybe even twice a year, they will take an inning of the baseball broadcast on TV and on the radio separately, and they will bring on either an oncologist or pulmonologist from one of the local cancer centers in our area, and the whole inning—between batters of course—they will talk about lung cancer screening and why it's beneficial.” TS 13:16 “Medicare always has its idiosyncrasies. So Medicare—I went over the rules with you, so the age, the smoking. They follow all of it, except they have a slight difference in age. They cover it for age 50 to 77, as opposed to 80.” TS 16:52 “I think just the other thing that people don't think about is that to go get a medical test done, no matter what test it is, typically people have to take time off of work. And it can be really hard to do that when you are relying on your job, maybe you don't have vacation time, maybe you have children at home that you need to get home to. When people are weighing the risk/benefit and thinking, ‘Well, I'd love to get screened for lung cancer, but I just can't find time to fit it into my schedule, and my job won't let me take off.' These are all things that we don't always think about if you have the luxury of just taking the day off.” TS 20:01

What inspires a company's commitment to community support and engagement? Michael Bland, Capital Project Stewardship Leader at Celanese, illustrates how their proactive approach led them to The Rose, supporting its mission through donations and involvement. From providing much-needed chemo kits to actively participating in community events, Celanese has become a partner rather than just a donor. Their employees, driven by values and empowered by the organization, strive to make a profound impact in the community. Key Questions Answered 1. What is Michael Bland's role at Celanese? 2. What does Michael enjoy most about his job at Celanese? 3. Can you explain what Celanese does as a company? 4. How did Celanese first become involved with The Rose? 5. What kind of community support has Celanese provided to The Rose? 6. Who did Michael Bland dress up as for the Shrimp Boil's 80s costume contest? 7. How did the Celanese team participate in the Shrimp Boil event? 8. What was the significance of the survivor's quilt mentioned in the episode? 9. How does Celanese view its role in community involvement, according to Michael Bland? 10. What is the "Keep the Mobile on the Road" program mentioned by Dorothy Gibbons? Timestamped Overview 00:00 "Breast Health Podcast: Community Support" 04:48 Celanese's Commitment to Community 07:11 Dressing as Slash and Axl, 1986 09:44 Affordable Shrimp Fundraiser & Community Event 14:15 Shared Enthusiasm Impresses New Visitor 16:51 Breaking Silence for Early Detection 21:09 Underestimated Support Logistics 22:13 Mobile Repair Fundraiser Program 25:14 Donations Support Trauma Recovery ProgramSee omnystudio.com/listener for privacy information.

HEALTH NEWS   Study Finds Green Tea may Heal Neurodegenerative Conditions like Alzheimer's High blood pressure? Eat more bananas Mediterranean diet and exercise may slow bone loss in aging women Can gut microbes help prevent Alzheimer's? Radiation from CT scans could account for 5% of all cancer cases a year, study suggests Thermography is Key for Early Detection of Breast Cancer  

Craig Cooper, former professional athlete and author of Your New Prime, shares the overlooked realities men face as they age. He opens up about reversing his own osteoporosis and why many men fail to prioritize bone health. Craig breaks down why typical fitness routines may actually accelerate aging and offers science-backed alternatives for maintaining strength, metabolic function, and cardiovascular resilience. This episode equips listeners with practical, often ignored insights into how to stay strong, capable, and engaged well beyond midlife.This May 26-31 in Santa Fe, NM, Rebecca Rusch and AGEIST founder David Stewart are hosting what might be the most transformative week of your year. It's what Rebecca calls "adult play summer camp," blending cutting-edge science with genuine joy.Ideal for all fitness levels – whether you're a seasoned athlete or just getting started on your wellness journey.Ready to feel better than you have in years? Your future self is waiting at meawisdom.com/enrollThanks to Our SponsorsBON CHARGE: What if there was a device that combined nature's beneficial frequencies with red, near-infrared, and far-infrared light? BON CHARGE's Infrared PEMF Mat Max is the all-in-one device that can help you recover faster, sleep better, elevate your focus, and achieve ultimate wellness. Use “AGEIST15” at checkout for 15% off your purchase.Timeline Nutrition: Our favorite supplement for cell support and mitochondrial function. Listeners receive 10% off your first order of Mitopure with the code “AGEIST” at TimelineNutrition.com/ageist.Our Place: Our top cookware brand for non-toxic, PFA-free pots and pans. Use code “AGEIST” for 10% off at fromourplace.com.Chapters(00:15) Introduction to Craig Cooper and His Journey(06:42) The Evolution of Health Perspectives in Aging(13:04) Bone Health: Overcoming Osteopenia(17:29) Cardiovascular Health and Longevity(24:48) Nutrition and Dietary Choices for Better Aging(26:57) Understanding Cardiovascular Health Tests(33:04) The Importance of Early Detection in Health(36:12) Cardiovascular Disease: The Leading Cause of Death(40:52) Practical Health Monitoring Tips(42:54) The Role of Personal Responsibility in Health(46:20) Inspiring Stories of Resilience and Health(52:12) Nutritional Strategies for Bone HealthKey Moments“Hormonally, [training] long slow distance just really just sucks your manhood.”“You really can't have a discussion around longevity without focusing on arterial health.”“I've had doctors come out of UCLA to look at what I've been doing… they've never seen this sort of switch that I've been able to execute on my bone health over the course of five years.”Connect With Craig CooperConneqt Health: conneqthealth.comLinkedIn: https://www.linkedin.com/in/craigcooper007/Say hi to the AGEIST team!

Updates in classification, evaluation, and treatment Become dexterous with dementia management! We're talking with Dr. Anna Chodos about cognitive domains, diagnostic criteria, patient and caregiver resources, new antibody therapies, and brain health plans!  Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid fire questions The Terminology of Neurocognitive Disorders Cognitive Domains: A Comprehensive Approach Physical Examination Insights Medical Workup for Dementia Imaging and Biomarkers in Dementia Diagnosis Referral Considerations for Dementia Patients Understanding Dementia Stages and Prognosis Implementing Brain Health Plans Medications for Dementia Management Controversies in Monoclonal Antibody Therapies The Importance of Early Detection and Planning Outro Credits Producers, Writers and Show Notes: Leah Witt, MD and Margaret Heller, MD Infographic and Cover Art: Leah Witt, MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Emi Okamoto, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Anna Chodos, MD Disclosures Dr. Chodos received remuneration from Novo Nordisk for participating in a task force looking at the feasibility of incorporating biomarkers for Alzheimer's disease into primary care. The financial relationship has ended. The Curbsiders report no relevant financial disclosures.  The production of this episode was supported by the Penn Geriatrics AGE-SMART Geriatric Workforce Enhancement Grant. This podcast content is solely the responsibility of the authors and does not necessarily represent the official views of the Health Resources and Services Administration or the U.S. Department of Health and Human Services. Sponsor: Locumstory Locumstory.com is simply a free, unbiased educational resource about locum tenens.  Sponsor: Grammarly  Download Grammarly for free at Grammarly.com/PODCAST Sponsor: Continuing Education Company Special offer for Curbsiders listeners: Save 30% on all online courses and live webcasts with promo code CURB30. Visit www.CMEmeeting.org/curbsiders to explore all offerings and claim your discount. Whether live, online, or on-demand, Continuing Education Company makes earning CME easy and rewarding.

In this episode of SHE MD, hosts Mary Alice Haney and Dr. Thaïs Aliabadi welcome Kate Bond, an actress best known for her roles in Chicago Med, Good Trouble, and the reboot of MacGyver. For over a decade, Kate silently struggled with endometriosis, a chronic condition that affects millions of women but is notoriously difficult to diagnose. Her story highlights the frustrations many women face in the healthcare system when dealing with this condition and getting dismissed by most doctors. Kate and the hosts explore the challenges of her diagnosis, the impact on daily life, and the knowledge you need to be your own health advocate.Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii. Sponsors: One Skin: Visit OneSkin.co/SHEMD and use code SHEMD at checkout for 15% off your first purchasePurely Elizabeth: Visit purelyelizabeth.com and use code SHEMD at checkout for 20% off. Purely Elizabeth. Taste the ObsessionSaks.com: Shop Saks.coCymbiotika: Go to Cymbiotikia.com/SHEMD for 20% off your order + free shipping today.Zoe: As a ZOE member, you'll get an at home test kit and personalized nutrition program to help make smarter food choices that support your gut. That's ZOE.com and use code SHEMD10 to get 10% off your membership.Momentous: Go to livemomentous.com and try it today for 20% off with code SHEMD, and start living on purpose.iRestore: Reverse hair loss with @irestorelaser and get $625 off with code shemd at https://www.irestorelaser.com/SHEMD! #irestorepodKATE BOND'S TAKEAWAYS:Endometriosis symptoms often include severe pelvic pain, painful periods, and gastrointestinal issues that can significantly impact daily life and work.Proper diagnosis and treatment of endometriosis often require finding a doctor who listens, shows empathy, and is curious about solving the patient's health puzzle.Suppression therapy after endometriosis surgery is crucial for long-term management and prevention of symptom recurrence.Proactive health screenings, including genetic testing and colonoscopies, are important for early detection of related health issues, especially for those with endometriosis.Some endometriosis treatment includes laparoscopic surgery with an experienced surgeon who can diagnose and treat endometriosis; hormonal suppression, like progesterone IUDs, often helps manage symptoms; Dietary changes may be necessary to address related GI issues like SIBO.IN THIS EPISODE: (00:00) Intro(03:25) Kate Bond's endometriosis diagnosis journey(04:50) Dr. Aliabadi explains endometriosis in detail(09:52) Kate describes severe endometriosis symptoms(21:15) Endometriosis impacts career and life(24:50) Treatment options for endometriosis explained(29:08) SIBO and endometriosis connection discussed(33:54) Importance of early colonoscopy screening(42:35) Life improvements after endometriosis treatment(45:02) Endometriosis impact on family planningRESOURCES:Kate Bond's InstagramGUEST BIOGRAPHY:Kate Bond grew up in an A-frame house at the end of a long dirt road in rural Georgia. She is an actress whose credits include Chicago Med, Good Trouble, and the reboot of MacGyver. She's a passionate unionist and serves on the board of directors of the Los Angeles local of SAG-AFTRA. Her story isn't just about making it in the entertainment industry—it's about breaking through barriers, both systemic and personal, and redefining what success looks like when life throws you curveballs. For over a decade, Kate silently struggled with endometriosis, a chronic condition that affects millions of women but is notoriously difficult to diagnose. Like so many others, she was dismissed by doctors, told that her pain was “normal,” and forced to keep pushing forward—because when you're trying to build a career in Hollywood, there's no calling in sick.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode Summary:In this episode of the Beautifully Broken Podcast, Kyle Samuels—Founder & CEO of Creative Talent Endeavors (CTE)—opens up about his unexpected journey through a pancreatic cancer diagnosis and what it taught him about self-advocacy, resilience, and the importance of early detection. Kyle's story is a raw and inspiring look at how one moment can shift everything—and how listening to your body (and your loved ones) can literally save your life.Together, we explore his role as a disruptor in executive recruiting, the cultural disparities in healthcare, and the power of community when navigating illness. This is a conversation about hope, awareness, and the healing that happens when you embrace being beautifully broken.HIGHLIGHTS[2:52] Kyle breaks down what's broken in traditional recruitment and what he's doing differently [6:05] The Friday night that changed everything: Kyle's mysterious symptoms lead to a shocking discovery [12:05] Why early detection and a simple blood test (CA 19-9) may have saved Kyle's life [17:48] Navigating treatment and the mental/emotional recovery that follows [28:39] Proactive scanning: the game-changer in catching cancer early [30:28] Building the mental strength to handle unexpected health journeys [33:20] Talking about health inequities and why cultural shifts are needed [40:25] Health behavior and awareness in different communities [41:16] Gratitude, healing, and the new mission that emerged from the painCONNECT WITH KYLEWebsite: https://www.hirecte.com/LinkedIn: https://www.linkedin.com/in/kylesamuels/UPGRADE YOUR WELLNESSSilver Biotics Wound Healing Gel: https://bit.ly/3JnxyDD (30% off)(Use Code: BEAUTIFULLYBROKEN for Discount)Saga Bands: https://ca.saga.fitness/?ref=titvyccmCode: beautifullybrokenStemRegen: https://www.stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52Code: beautifullybrokenLightPathLED https://lightpathled.pxf.io/c/3438432/2059835/25794Code: beautifullybroken CONNECT WITH FREDDIE Check out my website and store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: (https://www.youtube.com/@BeautifullyBrokenWorld)